Range of Long-Term Symptoms Seen After SARS-CoV-2, Non-COVID-19 ARI
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Oct. 23, 2023 -- There is a wide range of long-term symptoms associated with both severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and non-COVID-19 acute respiratory infections (ARIs), according to a study published online Oct. 6 in EClinicalMedicine.
Giulia Vivaldi, from the Queen Mary University of London, and colleagues compared symptom profiles between people with previous SARS-CoV-2 infection, people with previous non-COVID-19 ARIs, and contemporaneous controls. Data were analyzed for 16 potential long COVID symptoms and health-related quality of life (HRQoL) reported between Jan. 21 and Feb. 15, 2021, by individuals unvaccinated against SARS-CoV-2. Data were included for 10,171 participants (12.9 and 4.6 percent with SARS-CoV-2 infection and non-COVID-19 ARI, respectively).
The researchers found that both SARS-CoV-2 infection and non-COVID-19 ARI were associated with increased prevalence/severity of most symptoms and reduced HRQoL versus no infection. Increased odds of problems with taste/smell and lightheadedness or dizziness were seen for participants with SARS-CoV-2 infection versus those with non-COVID-19 ARIs (odds ratios, 19.74 and 1.74, respectively). Three symptom severity groups were identified for each infection type in separate latent class analysis models. In the most severe groups (representing 22 percent of participants in each group), SARS-CoV-2 infection presented with a higher probability of problems with taste/smell, hair loss, unusual sweating, unusual racing of the heart, and memory problems than non-COVID-19 ARI.
"Our findings shine a light not only on the impact of long COVID on people's lives, but also other respiratory infections," Vivaldi said in a statement. "A lack of awareness -- or even the lack of a common term -- prevents both reporting and diagnosis of these conditions."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Further Support and Information on COVID-19
Read this next
Preoxygenation With Noninvasive Ventilation Yields Lower Hypoxemia
FRIDAY, June 14, 2024 -- For critically ill adults undergoing tracheal intubation, preoxygenation with noninvasive ventilation results in lower incidence of hypoxemia than...
Residual Risk Seen for Death, Postacute Sequelae in Third Year After COVID-19 Hospitalization
THURSDAY, June 13, 2024 -- For individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the risks for death and postacute sequelae of COVID-19...
Systemic Side Effects of COVID-19 Vaccine Tied to Greater nAB Response
TUESDAY, June 11, 2024 -- Short-term systemic side effects of the severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA vaccine are associated with greater long-lasting...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.